Control mechanism of JAK/STAT signal transduction pathway

被引:148
作者
Yamada, S
Shiono, S
Joo, A
Yoshimura, A
机构
[1] Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo 6618661, Japan
[2] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan
来源
FEBS LETTERS | 2003年 / 534卷 / 1-3期
关键词
interferon-gamma; Janus kinase; signal transducer and activator of transcription; suppressor of cytokine signaling-1; nuclear tyrosine phosphatase;
D O I
10.1016/S0014-5793(02)03842-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Suppressor of cytokine signaling-1 (SOCS1) was identified as the negative regulator of Janus kinase (JAK) and signal transducer and activator of transcription (STAT) signal transduction pathway. However, the kinetics and control mechanism of the pathway have not yet been fully understood. We have developed the computer simulation of the JAK/STAT pathway. Without nuclear phosphatase, SOCS1's binding to JAK did not cause the decrease in nuclear phosphorylated STAT1. However, without SH2 domain-containing tyrosine phosphatase 2 (SHP-2) or cytoplasmic phosphatase, it did. So nuclear phosphatase is considered to be the most important in this system. By changing parameters of the model, dynamical characteristics and control mechanism were investigated. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:190 / 196
页数:7
相关论文
共 23 条
[1]   SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine [J].
Alexander, WS ;
Starr, R ;
Fenner, JE ;
Scott, GL ;
Handman, E ;
Sprigg, NS ;
Corbin, JE ;
Cornish, AL ;
Darwiche, R ;
Owczarek, CM ;
Kay, TWH ;
Nicola, NA ;
Hertzog, PJ ;
Metcalf, D ;
Hilton, DJ .
CELL, 1999, 98 (05) :597-608
[2]   Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor [J].
Bousquet, C ;
Susini, C ;
Melmed, S .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (09) :1277-1285
[3]   Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells [J].
Brightman, FA ;
Fell, DA .
FEBS LETTERS, 2000, 482 (03) :169-174
[4]   Suppressor of cytokine signaling-1 attenuates the duration of interferon γ signal transduction in vitro and in vivo [J].
Brysha, M ;
Zhang, JG ;
Bertolino, P ;
Corbin, JE ;
Alexander, WS ;
Nicola, NA ;
Hilton, DJ ;
Starr, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) :22086-22089
[5]   Suppressors of cytokine signaling (SOCS): Inhibitors of the JAK/STAT pathway [J].
Cooney, RN .
SHOCK, 2002, 17 (02) :83-90
[6]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[7]   A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box [J].
Hanada, T ;
Yoshida, T ;
Kinjyo, I ;
Minoguchi, S ;
Yasukawa, H ;
Kato, S ;
Mimata, H ;
Nomura, Y ;
Seki, Y ;
Kubo, M ;
Yoshimura, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :40746-40754
[8]   Mathematical models of protein kinase signal transduction [J].
Heinrich, R ;
Neel, BG ;
Rapoport, TA .
MOLECULAR CELL, 2002, 9 (05) :957-970
[9]   The Jak-STAT pathway [J].
Imada, K ;
Leonard, WJ .
MOLECULAR IMMUNOLOGY, 2000, 37 (1-2) :1-11
[10]   Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads [J].
Itoh, F ;
Asao, H ;
Sugamura, K ;
Heldin, CH ;
ten Dijke, P ;
Itoh, S .
EMBO JOURNAL, 2001, 20 (15) :4132-4142